Abstract
AbstractFunctionalized monodisperse microbubbles have the potential to boost the sensitivity and efficacy of molecular ultrasound imaging and targeted drug delivery using bubbles and ultrasound. Monodisperse bubbles can be produced in a microfluidic flow focusing device. However, their functionalization and sequential use require removal of the excess lipids from the bubble suspension to minimize the use of expensive ligands and to avoid competitive binding and blocking of the receptor molecules. To date, excess lipid removal is performed by centrifugation, which is labor intensive and challenging to automate. More importantly, as we show, the increased hydrostatic pressure during centrifugation can reduce bubble monodispersity. Here, we introduce a novel automated microfluidic ’washing’ method. First, bubbles are injected in a microfluidic chamber 1 mm in height where they are left to float against the top wall. Second, lipid-free medium is pumped through the chamber to remove excess lipids while the bubbles remain located at the top wall. Third, the washed bubbles are resuspended and removed from the device into a collection vial. We demonstrate that the present method can (i) reduce the excess lipid concentration by 4 orders of magnitude, (ii) be fully automated, and (iii) be performed in minutes while the size distribution, functionality, and acoustic response of the bubbles remain unaffected. Thus, the presented method is a gateway to the fully automated production of functionalized monodisperse microbubbles.
Publisher
Springer Science and Business Media LLC
Reference55 articles.
1. Seo, J. & Kim, Y.-S. Ultrasound imaging and beyond: recent advances in medical ultrasound. Biomed. 7, 57–58 (2017).
2. Frinking, P., Segers, T., Luan, Y. & Tranquart, F. Three decades of ultrasound contrast agents: a review of the past, present and future improvements. Ultrasound Med. Biol. 46, 892–908 (2020).
3. Versluis, M., Stride, E., Lajoinie, G., Dollet, B. & Segers, T. Ultrasound contrast agent modeling: a review. Ultrasound Med. Biol. 46, 2117–2144 (2020).
4. Averkiou, M. A., Bruce, M. F., Powers, J. E., Sheeran, P. S. & Burns, P. N. Imaging methods for ultrasound contrast agents. Ultrasound Med. Biol. 46, 498–517 (2020).
5. Borden, M. A. & Song, K.-H. Reverse engineering the ultrasound contrast agent. Adv. Colloid. Interface Sci. 262, 39–49 (2018).